eedq has been researched along with fluphenazine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldstein, M; Lew, JY; Meller, E | 1 |
Egawa, M; Friedhoff, AJ; Rosengarten, H; Schweitzer, JW | 1 |
Qin, ZH; Weiss, B | 1 |
Qin, ZH; Weiss, B; Zhou, LW | 1 |
Qin, ZH; Weiss, B; Zhang, SP | 1 |
Baldessarini, RJ; Gongwer, MA; Kula, NS; Neumeyer, JL; Yeghiayan, SK; Zong, R | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
7 other study(ies) available for eedq and fluphenazine
Article | Year |
---|---|
Photoaffinity labeling and purification of solubilized D2 dopamine receptors.
Topics: Affinity Labels; Animals; Azides; Fluphenazine; In Vitro Techniques; Molecular Weight; Quinolines; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Solubility | 1985 |
Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Disease Models, Animal; Dopamine Antagonists; Dyskinesia, Drug-Induced; Ergolines; Fluphenazine; Male; Quinolines; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Stereotyped Behavior | 1988 |
Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra.
Topics: Analysis of Variance; Animals; Autoradiography; Benzazepines; Binding, Competitive; Dopamine Antagonists; Fluphenazine; Gene Expression Regulation, Enzymologic; Glutamate Decarboxylase; Image Processing, Computer-Assisted; In Situ Hybridization; Male; Mice; Oligonucleotide Probes; Quinolines; Receptors, Dopamine D2; RNA, Messenger; Substantia Nigra | 1994 |
D2 dopamine receptor messenger RNA is altered to a greater extent by blockade of glutamate receptors than by blockade of dopamine receptors.
Topics: Animals; Autoradiography; Basal Ganglia; Brain Chemistry; Dizocilpine Maleate; Dopamine D2 Receptor Antagonists; Excitatory Amino Acid Antagonists; Fluphenazine; In Situ Hybridization; Male; Mice; Quinolines; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger | 1994 |
Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain.
Topics: Animals; Brain; Dizocilpine Maleate; Dopamine Antagonists; Fluphenazine; Glutamate Decarboxylase; In Situ Hybridization; Male; Mice; Oligonucleotide Probes; Quinolines; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate; RNA, Messenger | 1994 |
Local injection of alkylating and nonalkylating dopamine receptor antagonists into rat basal forebrain: autoradiographic assessment of D2-like and D3 sites.
Topics: Alkylating Agents; Animals; Autoradiography; Bacterial Toxins; Calcium-Binding Proteins; Dopamine Agonists; Dopamine Antagonists; Fluphenazine; Male; Microinjections; Nucleus Accumbens; Prosencephalon; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes; Type C Phospholipases | 1998 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |